Tags Posts tagged with "$MNTR"

$MNTR

0 1184

Mentor Capital Moves to OTCQB Venture Stage Market Feb 10th

Cannabis M&A Leader Continues Path Toward Larger Exchange Listing

Mentor Capital, Inc. (OTC Pink: MNTR) reports it received confirmation from OTC Markets Group that on February 10, 2015, Mentor Capital will move up to the OTCQB venture stage marketplace for early stage and developing companies under the newly modified ticker (MNTR). Mentor Capital CEO, Chet Billingsley, observes, “As we move to provide significant public market liquidity for medical marijuana company founders, it is important for participating institutional and public investors to have confidence in those associated cannabis related business disclosures. Mentor will now be able to provide that transparency into the otherwise uncertain marijuana sector by the combination of the required OTCQB certification, OTC Markets company profile postings, full EDGAR SEC reporting, and the SEC recognition of OTCQB as an Established Public Market.”

At this milestone, Mentor Capital is pleased to recall that in the fifteen years since the company reorganized in 2000, the market capitalization of the firm has increased 4,850% which corresponds to a 29.5% annualized growth, although future results will vary.

To ensure that certain shareholders, or often their estates, still holding residual warrants from the year 2000 have an alternative opportunity to participate in the historical upside in value that has occurred over time, the company is authorizing a partial redemption, all as provided in the reorganization order, of up to 1% per month of any unexercised warrants from 2000, if any. The ordered redemption price is 10 cents per warrant which may be paid by the company or its shareholder designees and flows through to the original holder or estate. During ongoing months, designees, if any, may exercise the redeemable warrants, if any, at 50% of the closing bid price at the end of the preceding month. Certain shareholders to whom this partial redemption may apply will be further noticed at their last known address with participation details, if any, all in accordance with the reorganization order.

About Mentor Capital: The company seeks to take significant positions in medical marijuana and cannabis companies to both provide public market liquidity for founders and to incubate private cannabis companies that have the potential to be spun off as stand-alone pubic companies. Additional important information for investors is presented at:www.MentorCapital.com.

This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.

Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales, problems securing the necessary financing to continue operations, problems involving continued illegality of cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, in recruiting knowledgeable personnel and in protecting intellectual property. Further information concerning these and other risks is included in the Company’s Form 10 filing which, along with other very important information about the Company, can be found here:

http://mentorcapital.com/disclosures/

The Company undertakes no obligation to update or revise such forward-looking statements to reflect new information, events or circumstances occurring after the date of this press release.

Contact:
Mentor Capital, Inc.
Chet Billingsley, CEO
760-788-4700

0 1394

Mentor Capital Selects Colorado Auditor for the Next Phase of Its Medical Marijuana and Cannabis Business

BF Borgers CPA PC of Lakewood, CO to Replace Albert Wong & Co., LLP as Company’s Public Accountant

SAN DIEGO–(BUSINESS WIRE)–

Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has engaged BF Borgers CPA PC as its new public accounting firm and has filed a Form 8-K with the SEC through the EDGAR system detailing this move to the Colorado based auditor. Mentor CEO Chet Billingsley observes, “Given our ongoing medical marijuana and cannabis focus, it made sense to move to an auditor in a state where many cannabis businesses are active and marijuana has been legalized at the state level. This further supports our earlier 2014 actions to progressively step up our reporting levels from limited information, to current information, and with the recent completion of two years of financial audits and an initial Form 10 filing, toward being fully reporting with the SEC.”

The Form 8-K, which indicates that there were no disagreements with the previous auditor, Albert Wong & Co. of New York and Hong Kong, nor any reportable events, can be referenced through the SEC’s EDGAR system at:

https://www.sec.gov/edgar/searchedgar/companysearch.html

Inputting the company name, Mentor Capital, Inc. or the company’s CIK code which is 0001599117, will bring up the report. The Form 8-K will also be able to be viewed at the company’s web site: www.MentorCapital.com at the Investor’s Corner section under the Disclosures tab.

About Mentor Capital: By acquisition or stock purchase, Mentor Capital, Inc. seeks to invest in leading cannabis companies. Additional important information for investors and founders seeking expansion funding is presented at the company website above.

This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.

Forward-Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” or “intends,” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales activities, problems securing the necessary financing to continue operations, problems encountered in commercializing cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, difficulties in recruiting knowledgeable personnel and potential problems in protecting intellectual property. Further information concerning these and other risks is included in the Company’s Form 10 filing which, along with other very important information about the Company, can be found here:

http://mentorcapital.com/disclosures/

The Company undertakes no obligation to update or revise such forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Contact:
Mentor Capital, Inc.
Chet Billingsley, CEO
(760) 788-4700

0 1481

Mentor Capital Issues Q3 Financials with $1.5 M Revenue YTD

$0.6 Million Cash, $5.5 Million in Assets with Non-Affiliate Debt at $0.2 Million Reported at Q3 along with 2013 and 2012 Audits

SAN DIEGO–(BUSINESS WIRE)– Mentor Capital, Inc. (OTC Markets: MNTR) announced its third quarter consolidated financial results in conjunction with its Form 10 filing which included 2013 and 2012 audited financial reports. The complete financial filing can be viewed at the company’s web site, at www.sec.gov and at the company’s Filings and Disclosure page at the OTCMarkets.com website under the Mentor Capital ticker (MNTR).

On an unaudited basis the company, as of September 30, 2014, reports that it holds $553,467 in cash, which is an increase from $40,184 held on December 31, 2013. As of September 30, 2014, the company had $2,664,141 in current assets which is an increase from $403,912 at 2013 year end. Consolidated total assets were $5,538,768 on September 30, 2014 which is an increase from $1,690,155 on December 31, 2013. Non-affiliate liabilities total $151,980 on September 30, 2013 compared to $27,366 on December 31, 2013. Common equity is $3,997,543 on September 30, 2014 which is an increase from the deficit of ($293,869) at December 31, 2013. The 2014 first nine month revenues were $1,546,128 compared to $24,000 for the first nine months of 2013. The company had a gross profit of $483,773 at Sept 30, 2014 YTD which compares to a gross profit of $24,000 at September 30, 2013 YTD. The net loss for the first nine months of 2014 was ($11,268) which is an improvement from the net loss of ($181,183) for the first nine months of 2013. 12,539,342 average diluted common shares were outstanding during the first nine months of 2014 vs. 6,650,227 during the same period of 2013.

Mentor Capital focuses new investments into the cannabis and medical marijuana space. Reported financial results are consolidated from several portfolio entities. Nevada Cannabis Ventures, Inc. is funding the formation of the management company for a hedge fund headquartered and somewhat focused in Nevada. MicroCannabiz provides a definitive directory of 4,500 cannabis entities, and other information related cannabis services. $1.5 Million was also paid through Bhang Corporation to Bhang owners, who have kept the $1.5 Million. They have refused to issue any Bhang shares to Mentor Capital, publicly repudiating the contract they signed a few months earlier. Mentor Capital is pursuing through the courts the return of the $1.5 Million which will be redeployed into the cannabis space. Mentor Capital focuses on investments in private medical marijuana companies but holds some few public cannabis shares in its stock portfolio. GW Pharmaceuticals is our largest holding there. Mentor Capital has transitioned out of all of its public cancer stocks and has only minority positions in Brighter Day Health and Shaw Capital (medical devices) as residual private cancer investments pending socially responsible exit opportunities. WCI is a final remaining significant non-cannabis legacy investment.

About Mentor Capital: By acquisition or stock purchase, Mentor Capital, Inc. seeks to invest in leading cannabis companies. Additional important information for investors and founders seeking expansion funding is presented at: www.MentorCapital.com

This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.

Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” or “intends,” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated.Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales activities, problems securing the necessary financing to continue operations, problems encountered in commercializing cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, difficulties in recruiting knowledgeable personnel and potential problems in protecting intellectual property. Further information concerning these and other risks is included in the Company’s Form 10 filing which, along with other very important information about the Company, can be found here: http://MentorCapital.com/disclosures/

The Company undertakes no obligation to update or revise such forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Contact:
Mentor Capital, Inc.
Chet Billingsley, CEO
(760) 788-4700

0 1443

Mentor Capital Moves Up to Fully Reporting with Initial Form 10

Marijuana and Cannabis Funder Continues Upward March Toward Larger Exchange Listing

SAN DIEGO–(BUSINESS WIRE)– Mentor Capital, Inc. (OTC Markets: MNTR) announced that it has filed its initial Form 10 through the EDGAR system and has opted to become fully reporting with the SEC. Mentor CEO, Chet Billingsley, observes, “Over the course of 2014 we have progressively stepped up our reporting levels from limited information, to current information, and now, with the completion of two years of financial audits, to fully reporting status with the SEC. We took this step earlier than securities law required because in the uncertain medical marijuana and cannabis sector, detailed and reliable disclosure is critical, especially to institutional investors.”

The Form 10 is the first of the 10K, 10Q family of ongoing reports that will now begin to be regularly filed by Mentor Capital with the SEC. Like with any of these reports, the Form 10 is subject to comment by the SEC staff. As the comments, if any, are being resolved, Mentor Capital, Inc. will apply to the OTC Markets Group to move up to being reported on their OTCQB system, according to the company.

The Form 10 which includes 2012 and 2013 audited financials, together with reviewed financials for the first nine months of 2014 can be referenced through the SEC’s EDGAR system at:

https://www.sec.gov/edgar/searchedgar/companysearch.html

Inputting the company name, Mentor Capital, Inc. or the company’s CIK code which is 0001599117, will bring up the report. The Form 10 can also be viewed at the company’s web site at the Investor’s Corner section under the Disclosures tab, that is at:

http://mentorcapital.com/wp-content/uploads/2014/01/Form-10-as-filed.pdf

Mentor Capital intends to release a discussion on its reported third quarter financial results, November 21, 2014.

About Mentor Capital: By acquisition or stock purchase, Mentor Capital, Inc. seeks to invest in leading cannabis companies. Additional important information for investors and founders seeking expansion funding is presented at:www.MentorCapital.com

This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.

Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” or “intends,” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales activities, problems securing the necessary financing to continue operations, problems encountered in commercializing cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, difficulties in recruiting knowledgeable personnel and potential problems in protecting intellectual property. Further information concerning these and other risks is included in the Company’s Form 10 filing which, along with other very important information about the Company, can be found here:

http://mentorcapital.com/disclosures/

The Company undertakes no obligation to update or revise such forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Contact:
Mentor Capital, Inc.
Chet Billingsley, CEO
(760) 788-4700

0 2277

Mentor Capital CEO Discusses Marijuana Investment in Forbes Magazine

In “Why Legalizing Medical Marijuana Will Make Investors Extremely Wealthy” by Mark Fidelman

Business Wire

SAN DIEGO–(BUSINESS WIRE)–

Mentor Capital, Inc. (OTC Markets: MNTR) is pleased that on election day Mentor’s comments on marijuana investing and the important topic of marijuana legalization are covered by Mark Fidelman in Forbes Magazine. He writes: “Will the federal government’s tacit overlooking of the national cannabis laws continue?” “The process of stepped legalization has started and continuing prospects look promising.” “Two-thirds (2/3) of the analysts love the potential of the marijuana industry since the $50 billion market is already developed, albeit illegal.”

In explaining cannabis investment during this transition to full legalization, Chet Billingsley, CEO of Mentor Capital, Inc. reports, “Marijuana investors repeat the tale of Joe Kennedy in the 1930’s and how he amassed a stock position before the lifting of prohibition and made a fortune from the re-legalization of alcohol. Many public companies [including Mentor Capital] are copying this model. They are positioning to have market share and established market presence when marijuana prohibition lifts.

“This makes the analysis of public marijuana stocks an indirect art rather than a financial science. Like selling picks and shovels to gold miners, there are legitimate investment purposes today in the marijuana industry by those that supply land, extraction equipment, insurance, financial services, software, consulting and the like. The establishment of brand identity, without actually `touching the bud,’ as they say, is also key in establishing a footprint in advance of the lifting of marijuana prohibition.

“But, many other companies do little more than attach `canna’ to their name and must be suspect,” Mr. Billingsley warns.

The full text of Mark Fidelman’s article in Forbes can be found at:http://www.forbes.com/sites/markfidelman/2014/11/04/why-legalizing-medical-marijuana-will-make-investors-extremely-wealthy/

About Mentor Capital: By acquisition or stock purchase, Mentor Capital, Inc. seeks to invest in leading cannabis companies. Additional important information for investors and founders seeking expansion funding is presented at:www.MentorCapital.com

This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.

Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” or “intends,” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales activities, problems securing the necessary financing to continue operations, problems encountered in commercializing cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, difficulties in recruiting knowledgeable personnel and potential problems in protecting intellectual property. Further information concerning these and other risks is included in the Company’s 15c2-11 filing which, along with other very important information about the Company, can be found here: http://mentorcapital.com/disclosures/

The Company undertakes no obligation to update or revise such forward-looking statements to reflect events or circumstances occurring after the date of this press release.

Contact:
Mentor Capital, Inc.
Chet Billingsley, CEO
(760) 788-4700

Subscribe Now & Begin Receiving Marijuana Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Marijuana Stocks, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on marijuana stocks related, articles, news and trade alerts. Further questions please contact privacy@marijuanastocks.com
Ad Placements